Health Canada inspection
Sanofi-Aventis Deutschland GmbH: Health Canada inspection of Mar 15, 2024
Health Canada · GMP · rating I
Key facts
| Establishment | Sanofi-Aventis Deutschland GmbH |
|---|---|
| City | Frankfurt am Main |
| Province | Hessen |
| Country | Germany |
| Program | GMP |
| Start date | Mar 15, 2024 |
| Rating | I |
| Rating description | Inspection in progress |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.